12 Health Care Stocks Moving In Monday's Pre-Market Session
Portfolio Pulse from Benzinga Insights
In Monday's pre-market session, several healthcare stocks experienced significant movements. Pasithea Therapeutics (KTTA) saw a sharp rise of 86.6%, while Assure Holdings (IONM) and Poseida Therapeutics (PSTX) also saw substantial gains. On the downside, Cogent Biosciences (COGT) and X4 Pharmaceuticals (XFOR) faced notable declines. These movements reflect changes in investor sentiment and could be driven by recent company news, market trends, or broader sector shifts.
December 11, 2023 | 1:06 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Assure Holdings' stock increased by 65.37% to $0.58, with a market cap of $3.8 million.
The significant rise in IONM's stock price suggests positive news or investor outlook, which could lead to further short-term appreciation.
CONFIDENCE 80
IMPORTANCE 85
RELEVANCE 100
POSITIVE IMPACT
Pasithea Therapeutics' stock soared by 86.6% in pre-market trading, with a market cap of $11.6 million.
The substantial pre-market gain for KTTA indicates a positive investor sentiment which could lead to a short-term increase in stock price if the momentum continues during regular trading hours.
CONFIDENCE 80
IMPORTANCE 90
RELEVANCE 100
POSITIVE IMPACT
Poseida Therapeutics' shares increased by 25.94% to $3.98, with a market cap of $380.5 million.
Poseida Therapeutics' notable pre-market gain could attract more investors, potentially leading to a short-term uptrend in its stock price.
CONFIDENCE 80
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Cogent Biosciences' stock declined by 26.5% to $6.35, with a market cap of $546.8 million.
The sharp decline in COGT's stock price could indicate negative sentiment or reactions to recent events, likely leading to a short-term downward trend.
CONFIDENCE 80
IMPORTANCE 85
RELEVANCE 100
NEGATIVE IMPACT
X4 Pharmaceuticals' stock fell 23.89% to $0.67, with a market value of $112.0 million.
X4 Pharmaceuticals' significant pre-market drop suggests potential negative developments or investor concerns, which could result in a short-term decrease in stock price.
CONFIDENCE 80
IMPORTANCE 80
RELEVANCE 100